PTK2 and neoplasm: We suggest that a gain of FAK activity within CAFs may provide an invasive advantage to well and differentiated tumour cells endowed with a low intrinsic invasive capacity (no epithelial–mesenchymal transition, EMT), and for which the biology of the tumour invasion process is still not clear.